• Join
  • Login
  • Contact

Search abstracts

Drug interactions and bleeding complications with rivaroxaban compared to warfarin

  • In: Poster presentation
  • At: Seoul (South Korea) (2017)
  • Type: Poster
  • Poster code: POS-PPR-001
  • By: CARDONA, Mark (Attard, Malta)
  • Co-author(s): Mark George Cardona
    Francesca Wirth
    Anthony Serracino-Inglott
    Lilian M Azzopardi
  • Abstract:


    Compared to warfarin, the novel oral anticoagulant (NOAC) rivaroxaban has fewer potential drug-drug interactions (DDIs). However, there is conflicting evidence regarding bleeding complications. 


    To compare rivaroxaban and warfarin with respect to potential DDIs and incidence and severity of bleeding.  


    Following ethics


  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses